GABPA antibody - C-terminal region (P100832_T100)
- Known as:
- GABPA (anti-) - C-terminal region (P100832_T100)
- Catalog number:
- p100832_t100
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Aviva Systems Biology
- Gene target:
- GABPA antibody - C-terminal region (P100832_T100)
Related genes to: GABPA antibody - C-terminal region (P100832_T100)
- Gene:
- GABPA NIH gene
- Name:
- GA binding protein transcription factor subunit alpha
- Previous symbol:
- -
- Synonyms:
- E4TF1A, NFT2, NRF2, E4TF1-60, NRF2A
- Chromosome:
- 21q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1994-01-18
- Date modifiied:
- 2018-04-23
Related products to: GABPA antibody - C-terminal region (P100832_T100)
Related articles to: GABPA antibody - C-terminal region (P100832_T100)
- The coexistence of and ( promoter alterations has been reported to cooperatively upregulate TERT expression and is well recognized as a biomarker for aggressive thyroid cancer. However, the mechanism underlying their synergistic effect remains elusive. - Source: PubMed
Publication date: 2026/01/22
Chen MengkeJiang KeZhang QiXiao XiZhu LefanSang YeHu GuanghuiYu ShuangHong ShubinLv WeimingXiao HaipengLiu Rengyun - Down syndrome (DS), caused by trisomy of chromosome 21, is the leading genetic cause of intellectual disability, yet the mechanisms disrupting fetal brain development remain unclear. We performed single-cell transcriptomic and chromatin accessibility profiling of approximately 250,000 cells from 15 DS and 15 control human fetal cortices (10-20 weeks postconception). Our analysis revealed a subtype-specific reduction in RORB- and FOXP1-expressing excitatory neurons and widespread disruption of neurodevelopmental transcriptional programs. Chromosome 21 transcription factors BACH1, PKNOX1 and GABPA emerged as dosage-sensitive hubs regulating genes linked to intellectual disability. Antisense oligonucleotide-mediated normalization of these transcription factors in human neural progenitors in vitro partially rescued target gene expression. Benchmarking a humanized in vivo model captured additional molecular and cellular signatures of DS, complementing the in vitro model. Together, we present a resource defining the gene-regulatory landscape underlying cortical development in DS and highlight molecular pathways for further investigation. - Source: PubMed
Publication date: 2026/01/16
Lattke MichaelTan Wee LengSukumaran Salil KalarikkalUtami Kagistia HanaSintes MarcosSakthivel SrinivasanTan JonathanLim AurielBansal Vibhavari AyshaRekopoulou KaterinaMatthews NikAlić IvanKrsnik ŽeljkaNižetić DeanLevi Boaz PDe Paola Vincenzo - Glioblastoma multiforme (GBM), the most aggressive primary brain tumor, is associated with extremely poor patient prognosis. Temozolomide (TMZ) resistance remains a major cause of treatment failure. Protein arginine methyltransferase 6 (PRMT6) plays critical roles in tumorigenesis, but its function and regulatory mechanisms in GBM TMZ resistance have not been elucidated. While the hypoxic microenvironment is a hallmark feature of GBM, its epigenetic regulatory mechanisms in drug resistance remain unclear. - Source: PubMed
Publication date: 2026/01/02
Chen ShuyangYu PengSun YongqingYan YutingZhang BoxiangLi Guangyu - KRAS-mutant lung adenocarcinoma (LUAD), due to its evolution of more complex antioxidant metabolic mechanisms, exhibits poorer sensitivity to conventional platinum-based drugs compared to other types of LUAD. Ferroptosis, as a means of inducing cell death in cancer therapy, shows unique features and potential therapeutic effects compared to the conventional form of apoptosis, which is frequently obstructed by drug resistance. In human KRAS-mutant LUAD cell lines and mouse models, we found that the deubiquitinase OTU deubiquitinase 7A (OTUD7A) precisely regulates the lysine demethylase 5B (KDM5B). Inhibition of KDM5B expression increases the H4K20me3 level, which in turn downregulates the expression of transcription factor GABPA associated with mitochondrial function, ultimately promoting the production of more Reactive Oxygen Species (ROS) by mitochondria and inducing ferroptosis. Additionally, in in vivo organoid models, cisplatin (CDDP) induced ferroptosis combined with GABPA inhibition demonstrated superior anticancer effects compared to conventional platinum-based drugs. This research identifies new targets and regulatory networks that hold promise for developing ferroptosis-based therapies for KRAS-mutant LUAD. - Source: PubMed
Publication date: 2025/12/20
Si RujiaShen ZiyangSui YingShi YueZhang YihanHu BowenChen XinFeng BingZhu Miao LinSha XiaofengDing NingZhou GuorenJiang FengXu CongShen Bo - Ulcerative colitis (UC), a chronic and relapsing form of inflammatory bowel disease (IBD), arises from a multifactorial interplay of genetic predisposition, immune dysregulation, and environmental triggers. Despite advances in understanding UC pathogenesis, the identification of reliable biomarkers and key regulatory genes remains essential for unraveling disease mechanisms. Such insights are crucial for improving diagnostic precision and developing personalized therapeutic strategies. - Source: PubMed
Publication date: 2025/11/01
Rahman Sheikh AtikurKhatun Mst TaniaSingh MahendraBiswas Viplov KumarHoque ForkanulZaman Nurun NesaParvin AnzanaUddin Mohammad Khaja MafijSheikh Md Mominul IslamBegum Most MoriumArya RakeshFaruquee Hossain Md